Vivitonin for Dogs | 
Vivitonin is a drug used to improve some of the signs of old age. It acts to increase blood flow to the heart, brain and muscle. It is used in dogs which are lacking in energy or seem vacant and unwilling to exercise or show interest in their surroundings. Although you cannot necessarily teach an old dog new tricks, many old
dogs do show a distinct improvement in demeanour and activity levels.
The effects of Vivitonin (which contains the drug propentofylline)
include opening up airways and blood vessels, providing more oxygen to
the brain, heart and muscles. Vivitonin is a safe drug which is very
rarely associated with any side effects, and you can often help an old
dog which seemed just to be "getting old". | | | | |
| Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction 
Company name: MSD Animal Health
Address: Walton Manor
Walton
Milton Keynes
MK7 7AJ
Telephone: 01908 685685 (Customer Support Centre)
Fax: 01908 685555
Email: vet-support.uk@merck.com
Website: www.msd-animal-health.co.uk
Presentation
Vivitonin 50 mg tablets are orange-yellow, film-coated tablets,
quarter-scored on one side. Each tablet contains 50 mg of the xanthine
derivative Propentofylline.
Vivitonin 100 mg tablets are orange-yellow, oblong film-coated tablets,
half-scored on one side. Each tablet contains 100 mg of the xanthine
derivative Propentofylline.
Uses
For improvement in dullness, lethargy and overall demeanour in dogs.
Vivitonin is particularly useful in older dogs, where it may increase
willingness to exercise and exercise tolerance.
Propentofylline has been shown to increase blood flow, particularly of
the heart and skeletal muscle. It also increases the blood flow of the
brain and therefore its oxygen supply, without increasing the brain's
glucose demand.
It has a modest positive chronotropic effect and a marked positive
inotropic effect. In addition, it has been shown to have an
anti-arrhythmic effect in dogs with myocardial ischemia and a
bronchodilator action equivalent to that of aminophylline.
Propentofylline inhibits platelet aggregation and improves the flow
properties of erythrocytes. It has a direct effect on the heart and
reduces peripheral vascular resistance thereby lowering cardiac load.
Some symptoms or conditions related to impaired blood circulation where Vivitonin may be of benefit are:
•Dullness, lethargy and depressed demeanour.
•Decreased willingness to exercise and exercise tolerance.
•Arryhthmia due to myocardial ischaemia.
•Conditions requiring improved circulation in the heart, brain and skeletal muscle.
Dosage and administration Vivitonin 50 mg tablets
One tablet per 10 kg bodyweight twice a day. The tablets may be halved.
Dogs of less than 5 kg may receive a quarter tablet twice a day.
Divide the tablets in halves and quarters with a knife or with a tablet splitter.
Dogs of 20 kg or more can be given Vivitonin 100 mg tablets.
Vivitonin 100 mg tablets
One tablet per 20 kg bodyweight twice a day.
Vivitonin 100 mg tablets may be halved but should not be quartered.
For larger dogs more accurate dosing may be achieved using a combination
of Vivitonin 100 mg and Vivitonin 50 mg tablets. Divide the tablets in
halves with a knife or with a tablet splitter.
Dogs of less than 20 kg can be given Vivitonin 50 mg tablets.
Weight
| 50mg
| 100mg
| < 5 kg
| ¼ tab bid
| -
| 5 kg
| ½ tab bid
| -
| 10 kg
| 1 tab bid
| -
| 15 kg
| 1½ tabs bid
| -
| 20 kg
| -
| 1 tab bid
| 30 kg
| -
| 1½ tabs bid
| 40 kg
| -
| 2 tabs bid
|
The tablets can be administered directly onto the back of the dog's
tongue or can be mixed in a small ball of food and should be
administered at least 30 minutes before feeding. Contra-indications, warnings, etc
Do not administer to pregnant bitches or breeding animals, as it has not yet been evaluated in this class of animal.
Specific diseases (e.g. kidney disease) should receive appropriate treatment.
Consideration should be given to rationalising the medication of dogs
already receiving treatment for congestive heart failure or bronchial
disease.
In the rare event of allergic skin reactions, treatment with the product should be stopped.
Operator warnings
Care should be taken to avoid accidental ingestion.
Wash hands after use.
For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Store in a dry place.
Keep blister pack in outer carton.
Disposal
Dispose of empty packaging in the household refuse. Unused product should be returned to the veterinary surgeon for disposal.
Legal category
POM-V
Packaging Quantities
Vivitonin 50 mg tablets – Packs of 2 x 30 tablets.
Vivitonin 100 mg tablets – Packs of 6 x 10 tablets.
Further information
Nil.
Marketing authorisation number(s) Vivitonin 50 mg tablets
| Vm 01708/4417
| Vivitonin 100 mg tablets
| Vm 01708/4446
|
Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: MSD Animal Health
Address: Walton Manor
Walton
Milton Keynes
MK7 7AJ
Telephone: 01908 685685 (Customer Support Centre)
Fax: 01908 685555
Email: vet-support.uk@merck.com
Website: www.msd-animal-health.co.uk
Presentation
Vivitonin 50 mg tablets are orange-yellow, film-coated tablets,
quarter-scored on one side. Each tablet contains 50 mg of the xanthine
derivative Propentofylline.
Vivitonin 100 mg tablets are orange-yellow, oblong film-coated tablets,
half-scored on one side. Each tablet contains 100 mg of the xanthine
derivative Propentofylline.
Uses
For improvement in dullness, lethargy and overall demeanour in dogs.
Vivitonin is particularly useful in older dogs, where it may increase
willingness to exercise and exercise tolerance.
Propentofylline has been shown to increase blood flow, particularly of
the heart and skeletal muscle. It also increases the blood flow of the
brain and therefore its oxygen supply, without increasing the brain's
glucose demand.
It has a modest positive chronotropic effect and a marked positive
inotropic effect. In addition, it has been shown to have an
anti-arrhythmic effect in dogs with myocardial ischemia and a
bronchodilator action equivalent to that of aminophylline.
Propentofylline inhibits platelet aggregation and improves the flow
properties of erythrocytes. It has a direct effect on the heart and
reduces peripheral vascular resistance thereby lowering cardiac load.
Some symptoms or conditions related to impaired blood circulation where Vivitonin may be of benefit are:
•Dullness, lethargy and depressed demeanour.
•Decreased willingness to exercise and exercise tolerance.
•Arryhthmia due to myocardial ischaemia.
•Conditions requiring improved circulation in the heart, brain and skeletal muscle.
Dosage and administration Vivitonin 50 mg tablets
One tablet per 10 kg bodyweight twice a day. The tablets may be halved.
Dogs of less than 5 kg may receive a quarter tablet twice a day.
Divide the tablets in halves and quarters with a knife or with a tablet splitter.
Dogs of 20 kg or more can be given Vivitonin 100 mg tablets.
Vivitonin 100 mg tablets
One tablet per 20 kg bodyweight twice a day.
Vivitonin 100 mg tablets may be halved but should not be quartered.
For larger dogs more accurate dosing may be achieved using a combination
of Vivitonin 100 mg and Vivitonin 50 mg tablets. Divide the tablets in
halves with a knife or with a tablet splitter.
Dogs of less than 20 kg can be given Vivitonin 50 mg tablets.
Weight
| 50mg
| 100mg
| < 5 kg
| ¼ tab bid
| -
| 5 kg
| ½ tab bid
| -
| 10 kg
| 1 tab bid
| -
| 15 kg
| 1½ tabs bid
| -
| 20 kg
| -
| 1 tab bid
| 30 kg
| -
| 1½ tabs bid
| 40 kg
| -
| 2 tabs bid
|
The tablets can be administered directly onto the back of the dog's
tongue or can be mixed in a small ball of food and should be
administered at least 30 minutes before feeding. Contra-indications, warnings, etc
Do not administer to pregnant bitches or breeding animals, as it has not yet been evaluated in this class of animal.
Specific diseases (e.g. kidney disease) should receive appropriate treatment.
Consideration should be given to rationalising the medication of dogs
already receiving treatment for congestive heart failure or bronchial
disease.
In the rare event of allergic skin reactions, treatment with the product should be stopped.
Operator warnings
Care should be taken to avoid accidental ingestion.
Wash hands after use.
For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Store in a dry place.
Keep blister pack in outer carton.
Disposal
Dispose of empty packaging in the household refuse. Unused product should be returned to the veterinary surgeon for disposal.
Legal category
POM-V
Packaging Quantities
Vivitonin 50 mg tablets – Packs of 2 x 30 tablets.
Vivitonin 100 mg tablets – Packs of 6 x 10 tablets.
Further information
Nil.
Marketing authorisation number(s) Vivitonin 50 mg tablets
| Vm 01708/4417
| Vivitonin 100 mg tablets
| Vm 01708/4446
|
Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: MSD Animal Health
Address: Walton Manor
Walton
Milton Keynes
MK7 7AJ
Telephone: 01908 685685 (Customer Support Centre)
Fax: 01908 685555
Email: vet-support.uk@merck.com
Website: www.msd-animal-health.co.uk
Presentation
Vivitonin 50 mg tablets are orange-yellow, film-coated tablets, quarter-scored on one side. Each tablet contains 50 mg of the xanthine derivative Propentofylline.
Vivitonin 100 mg tablets are orange-yellow, oblong film-coated tablets, half-scored on one side. Each tablet contains 100 mg of the xanthine derivative Propentofylline.
Uses
For improvement in dullness, lethargy and overall demeanour in dogs. Vivitonin is particularly useful in older dogs, where it may increase willingness to exercise and exercise tolerance.
Propentofylline has been shown to increase blood flow, particularly of the heart and skeletal muscle. It also increases the blood flow of the brain and therefore its oxygen supply, without increasing the brain's glucose demand.
It has a modest positive chronotropic effect and a marked positive inotropic effect. In addition, it has been shown to have an anti-arrhythmic effect in dogs with myocardial ischemia and a bronchodilator action equivalent to that of aminophylline.
Propentofylline inhibits platelet aggregation and improves the flow properties of erythrocytes. It has a direct effect on the heart and reduces peripheral vascular resistance thereby lowering cardiac load.
Some symptoms or conditions related to impaired blood circulation where Vivitonin may be of benefit are:
•Dullness, lethargy and depressed demeanour.
•Decreased willingness to exercise and exercise tolerance.
•Arryhthmia due to myocardial ischaemia.
•Conditions requiring improved circulation in the heart, brain and skeletal muscle.
Dosage and administration Vivitonin 50 mg tablets
One tablet per 10 kg bodyweight twice a day. The tablets may be halved.
Dogs of less than 5 kg may receive a quarter tablet twice a day.
Divide the tablets in halves and quarters with a knife or with a tablet splitter.
Dogs of 20 kg or more can be given Vivitonin 100 mg tablets.
Vivitonin 100 mg tablets
One tablet per 20 kg bodyweight twice a day.
Vivitonin 100 mg tablets may be halved but should not be quartered.
For larger dogs more accurate dosing may be achieved using a combination of Vivitonin 100 mg and Vivitonin 50 mg tablets. Divide the tablets in halves with a knife or with a tablet splitter.
Dogs of less than 20 kg can be given Vivitonin 50 mg tablets.
Weight
| 50mg
| 100mg
| < 5 kg
| ¼ tab bid
| -
| 5 kg
| ½ tab bid
| -
| 10 kg
| 1 tab bid
| -
| 15 kg
| 1½ tabs bid
| -
| 20 kg
| -
| 1 tab bid
| 30 kg
| -
| 1½ tabs bid
| 40 kg
| -
| 2 tabs bid
|
The tablets can be administered directly onto the back of the dog's tongue or can be mixed in a small ball of food and should be administered at least 30 minutes before feeding. Contra-indications, warnings, etc
Do not administer to pregnant bitches or breeding animals, as it has not yet been evaluated in this class of animal.
Specific diseases (e.g. kidney disease) should receive appropriate treatment.
Consideration should be given to rationalising the medication of dogs already receiving treatment for congestive heart failure or bronchial disease.
In the rare event of allergic skin reactions, treatment with the product should be stopped.
Operator warnings
Care should be taken to avoid accidental ingestion.
Wash hands after use.
For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Store in a dry place.
Keep blister pack in outer carton.
Disposal
Dispose of empty packaging in the household refuse. Unused product should be returned to the veterinary surgeon for disposal.
Legal category
POM-V
Packaging Quantities
Vivitonin 50 mg tablets – Packs of 2 x 30 tablets.
Vivitonin 100 mg tablets – Packs of 6 x 10 tablets.
Further information
Nil.
Marketing authorisation number(s) Vivitonin 50 mg tablets
| Vm 01708/4417
| Vivitonin 100 mg tablets
| Vm 01708/4446
|
Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: MSD Animal Health
Address: Walton Manor
Walton
Milton Keynes
MK7 7AJ
Telephone: 01908 685685 (Customer Support Centre)
Fax: 01908 685555
Email: vet-support.uk@merck.com
Website: www.msd-animal-health.co.uk
Presentation
Vivitonin 50 mg tablets are orange-yellow, film-coated tablets,
quarter-scored on one side. Each tablet contains 50 mg of the xanthine
derivative Propentofylline.
Vivitonin 100 mg tablets are orange-yellow, oblong film-coated tablets,
half-scored on one side. Each tablet contains 100 mg of the xanthine
derivative Propentofylline.
Uses
For improvement in dullness, lethargy and overall demeanour in dogs.
Vivitonin is particularly useful in older dogs, where it may increase
willingness to exercise and exercise tolerance.
Propentofylline has been shown to increase blood flow, particularly of
the heart and skeletal muscle. It also increases the blood flow of the
brain and therefore its oxygen supply, without increasing the brain's
glucose demand.
It has a modest positive chronotropic effect and a marked positive
inotropic effect. In addition, it has been shown to have an
anti-arrhythmic effect in dogs with myocardial ischemia and a
bronchodilator action equivalent to that of aminophylline.
Propentofylline inhibits platelet aggregation and improves the flow
properties of erythrocytes. It has a direct effect on the heart and
reduces peripheral vascular resistance thereby lowering cardiac load.
Some symptoms or conditions related to impaired blood circulation where Vivitonin may be of benefit are:
•Dullness, lethargy and depressed demeanour.
•Decreased willingness to exercise and exercise tolerance.
•Arryhthmia due to myocardial ischaemia.
•Conditions requiring improved circulation in the heart, brain and skeletal muscle.
Dosage and administration Vivitonin 50 mg tablets
One tablet per 10 kg bodyweight twice a day. The tablets may be halved.
Dogs of less than 5 kg may receive a quarter tablet twice a day.
Divide the tablets in halves and quarters with a knife or with a tablet splitter.
Dogs of 20 kg or more can be given Vivitonin 100 mg tablets.
Vivitonin 100 mg tablets
One tablet per 20 kg bodyweight twice a day.
Vivitonin 100 mg tablets may be halved but should not be quartered.
For larger dogs more accurate dosing may be achieved using a combination
of Vivitonin 100 mg and Vivitonin 50 mg tablets. Divide the tablets in
halves with a knife or with a tablet splitter.
Dogs of less than 20 kg can be given Vivitonin 50 mg tablets.
Weight
| 50mg
| 100mg
| < 5 kg
| ¼ tab bid
| -
| 5 kg
| ½ tab bid
| -
| 10 kg
| 1 tab bid
| -
| 15 kg
| 1½ tabs bid
| -
| 20 kg
| -
| 1 tab bid
| 30 kg
| -
| 1½ tabs bid
| 40 kg
| -
| 2 tabs bid
|
The tablets can be administered directly onto the back of the dog's
tongue or can be mixed in a small ball of food and should be
administered at least 30 minutes before feeding. Contra-indications, warnings, etc
Do not administer to pregnant bitches or breeding animals, as it has not yet been evaluated in this class of animal.
Specific diseases (e.g. kidney disease) should receive appropriate treatment.
Consideration should be given to rationalising the medication of dogs
already receiving treatment for congestive heart failure or bronchial
disease.
In the rare event of allergic skin reactions, treatment with the product should be stopped.
Operator warnings
Care should be taken to avoid accidental ingestion.
Wash hands after use.
For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Store in a dry place.
Keep blister pack in outer carton.
Disposal
Dispose of empty packaging in the household refuse. Unused product should be returned to the veterinary surgeon for disposal.
Legal category
POM-V
Packaging Quantities
Vivitonin 50 mg tablets – Packs of 2 x 30 tablets.
Vivitonin 100 mg tablets – Packs of 6 x 10 tablets.
Further information
Nil.
Marketing authorisation number(s) Vivitonin 50 mg tablets
| Vm 01708/4417
| Vivitonin 100 mg tablets
| Vm 01708/4446
|
Vivitreats help to give tablets and are delicious to dogs. Vivitreats are a soft and tasty treat in the shape of a cylinder which can be pressed and molded around a tablet. They are designed to help administer tablets to your dog simply, easily and without fuss. Designed to help alleviate problems that dog owners often have administering tablets long-term, which can lead to vital tablets being missed or treatment being abandoned, Vivitreat is a soft and tasty treat that owners can use to administer any medication. The medication is disguised within the treat by inserting the tablet into its centre and moulding the Vivitreat around it until completely enclosed.
Especially designed for use with Vivitonin tablets, but can be used with any tablets.
30 treats per packet. | 
